Molecular Partners AG (MOLN) stock surged on Monday, Here is why?
The stock of Molecular Partners AG (MOLN) gained significantly on Monday after the company announced the topline data from the phase 2 study for Endovibep which is an antiviral treatment for Covid-19. The stock of Molecular Partners AG (MOLN) soared 30.46% to $21.50 from the previously closed value. Reason for the MOLN stock gain Molecular […]